Poor trial results may prompt maker to pull ALS drug from market
Following disappointing trial results, the maker of a controversial ALS drug may pull the medication off the market.
Mar 11, 2024
0
0
Following disappointing trial results, the maker of a controversial ALS drug may pull the medication off the market.
Mar 11, 2024
0
0
Every year, more than 20,000 people in Germany die of blood cancer. It is the most common type of cancer in children. Donations of stem cells from blood or bone marrow increase the chance of survival for people suffering ...
Mar 11, 2024
0
0
Colonic diverticulosis is a prevalent condition among older adults, marked by the presence of thin-walled pockets in the colon wall that can become inflamed and infected; they can then hemorrhage or rupture. A new study, ...
Mar 11, 2024
0
0
A new study from Karolinska Institutet in Sweden reveals that immune cells in the liver react to high cholesterol levels and eat up excess cholesterol that can otherwise cause damage to arteries. The findings, published in ...
Mar 11, 2024
0
114
Adult stem cells have attracted great scientific interest because of their ability to self-renew and differentiate into other cell types. In an article published in Nature Communications, researchers reveal a new mechanism ...
Mar 11, 2024
0
0
The structure and functions of the tip of migrating neurons remain elusive. A research group has found that the PTPĪ-expressing growth cone senses the extracellular matrix and drives neuronal migration in the injured brain, ...
Mar 11, 2024
0
22
All living cells teem with ribonucleic acid (RNA), molecules that relay genetic messages to keep cells functioning. But these necessary molecules can also set off cellular alarms. The long twisted-together strands of RNA ...
Mar 11, 2024
0
1
How does your immune system decide between fighting invading pathogens now or preparing to fight them in the future? Turns out, it can change its mind.
Mar 10, 2024
0
37
New research from Oregon Health & Science University describes the science behind a promising technique to treat infertility by turning a skin cell into an egg that is capable of producing viable embryos.
Mar 8, 2024
0
73
Insights into the workings of an immune cell surface receptor, called PD-1, reveal how treatments that restrict its action can potentially be strengthened to improve their anticancer effect, a new study shows. The same findings ...
Mar 8, 2024
0
29